Position in TRLV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$228,056
New position
Shares Held
23,200
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $2,181,659 across 9 Drug Manufacturers - Specialty & Generic names. TRLV ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
30,583 | $752,647 | |
| 2 | ZTS |
Zoetis Inc.
|
7,817 | $561,729 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
This page
|
23,200 | $228,056 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,497 | $220,118 | |
| 5 | AKBA |
Akebia Therapeutics, Inc.
|
180,002 | $205,202 | |
| 6 | HLN |
Haleon plc
|
10,230 | $95,445 | |
| 7 | RMTI |
Rockwell Medical, Inc.
|
15,184 | $83,510 | |
| 8 | OGI |
Organigram Global Inc.
|
18,522 | $18,892 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,056 | 23,200 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||